In addition, studies showed identical or only modestly elevated RAS-GTP levels in NF1-deficient human neuroblastoma cells, in contrast to highly elevated RAS-GTP levels in NF1-deficient Schwannoma tumor cells (Johnson et al., 1993; The et al., 1993). This evidence concerns the gene NF1 and schwannoma.